home *** CD-ROM | disk | FTP | other *** search
Text File | 1993-11-11 | 56.4 KB | 1,130 lines |
- Newsgroups: sci.med.aids,soc.motss,sci.med,sci.answers,soc.answers,news.answers
- Path: senator-bedfellow.mit.edu!bloom-beacon.mit.edu!noc.near.net!MathWorks.Com!europa.eng.gtefsd.com!howland.reston.ans.net!wupost!wubios.wustl.edu!sma
- From: aids-request@cs.ucla.edu (Sci.med.aids Moderation Team)
- Subject: AIDS FAQ part1of4: Frequently Asked Questions with Answers
- Message-ID: <aids-faq1-11-1993@wustl.wubios.edu>
- Followup-To: poster
- Summary: Please read this before posting to sci.med.aids.
- Keywords: FAQ, AIDS, HIV
- Sender: sma@wubios.wustl.edu (sci.med.aids)
- Supersedes: <aids-faq1-10-1993@wustl.wubios.edu>
- Organization: Division of Biostatistics, WUMS, St. Louis, MO
- Date: Wed, 10 Nov 1993 17:38:22 GMT
- Approved: greening@sti.com (Dan R. Greening)
- sma@wustl.wubios.edu (Sci.med.aids Moderation Team)
- Expires: Wed, 15 Dec 1993 17:38:22 GMT
- Lines: 1111
- Xref: senator-bedfellow.mit.edu sci.med.aids:7528 soc.motss:175935 sci.med:72250 sci.answers:619 soc.answers:629 news.answers:14493
-
- Archive-Name: aids-faq1
- Last-Modified: 10 Nov 1993
-
- Welcome to the sci.med.aids, the international newsgroup on the Acquired
- Immune Deficiency Syndrome (see Q1.1 `What is sci.med.aids?' for more
- details).
-
- This article, called the sci.med.aids "FAQ", answers frequently asked
- questions about AIDS and the sci.med.aids newsgroup. The FAQ is posted
- monthly to sci.med.aids and related newsgroups. If you are new to
- sci.med.aids, please read it before posting articles or responses. If you
- are a sci.med.aids veteran, please skim the FAQ occasionally. You may
- find something new here.
-
- Please contribute to the sci.med.aids FAQ. Currently there are some
- gaping holes. Send suggested changes to aids-request@cs.ucla.edu. You
- don't have to format it: just send it.
-
- You can skip to a particular question by searching for `Question n.n'.
- See Q9.2 `Formats in which this FAQ is available' for details of where to
- get the PostScript and Emacs Info versions of this document.
-
- ===============================================================================
-
- Contents
-
- Section 1. Introduction and General Information
- Q1.1 What is sci.med.aids?
- Q1.2 Discussion topics.
- Q1.3 Sci.med.aids distribution.
- Q1.4 Subscribing and unsubscribe to sci.med.aids.
- Q1.5 What is a moderated newsgroup?
- Q1.6 Editorial guidelines.
- Q1.7 How do I submit a posting?
- Q1.8 The moderators.
- Q1.9 Cooperative moderation.
- Q1.10 Discussing sci.med.aids moderation policies.
-
- Section 2. How to prevent infection.
- Q2.1 How is AIDS transmitted?
- Q2.2 How effective are condoms?
- Q2.3 How do you minimize your odds of getting infected?
- Q2.4 How risky is a blood transfusion?
- Q2.5 Can mosquitoes transmit AIDS?
- Q2.6 What about other insect bites?
- Q2.7 Is there even a remote chance of insect transmission?
-
- Section 3. Confidentiality.
- Q3.1 How is blood tested in the United States?
- Q3.2 What if a blood-bank finds out you are HIV positive?
-
- Section 4. Treatment options.
- Q4.1 General treatment information.
- Q4.2 AIDS and Opportunistic Infections.
- Q4.3 Guide to Social Security Benefits.
- Q4.4 What if you can't afford AZT?
- Q4.5 What about DNCB? (please contribute)
-
- Section 5. The common debates.
- Q5.1 What are Strecker and Segal's theories that HIV is manmade?
- Q5.2 Other conspiracy theories.
- Q5.3 Duesberg's Risk-Group Theory
- Q5.4 Contaminated polio vaccine? (please contribute)
- Q5.5 Who is Lorraine Day? (please contribute)
-
- Section 6. Internet resources.
- Q6.1 Ben Gardiner's Gopher AIDS Database
- Q6.2 CDC AIDS Public Information Dataset.
- Q6.3 HIVNET/AEGIS Gateway (BETA VERSION)
- Q6.4 Other USENET newsgroups.
-
- Section 7. Other Electronic Information Sources.
- Q7.1 Ben Gardiner's list of AIDS BBSes.
- Q7.2 National AIDS Clearinghouse Guide to AIDS BBSes.
- Q7.3 National Library of Medicine AIDSLINE (please contribute)
- Q7.4 Commercial Bulletin Boards
- Q7.5 Reappraisal of the HIV-AIDS Hypothesis.
- Q7.6 Lesbian/Gay Scholars Directory.
-
- Section 8. Non-Electronic Information Sources.
- Q8.1 Phone Information about AIDS.
- Q8.2 Phone Information about AIDS drug trials.
- Q8.3 US Social Security: Information for Organizations
-
- Section 9. Administrative information and acknowledgements
- Q9.1 Feedback is invited
- Q9.2 Formats in which this FAQ is available
- Q9.3 Authorship and acknowledgements
-
- ===============================================================================
-
- Section 1. Introduction and General Information
-
- Q1.1 What is sci.med.aids?
- Q1.2 Discussion topics.
- Q1.3 Sci.med.aids distribution.
- Q1.4 Subscribing and unsubscribe to sci.med.aids.
- Q1.5 What is a moderated newsgroup?
- Q1.6 Editorial guidelines.
- Q1.7 How do I submit a posting?
- Q1.8 The moderators.
- Q1.9 Cooperative moderation.
- Q1.10 Discussing sci.med.aids moderation policies.
-
- -------------------------------------------------------------------------------
-
- Question 1.1. What is sci.med.aids?
-
- "sci.med.aids" is a USENET newsgroup which discusses AIDS and HIV. A
- gateway forwards articles posted to sci.med.aids to a BITNET listserv
- mailing list called AIDS.
-
- Thousands read sci.med.aids, including people with HIV infections,
- published authors, researchers, public health officials, and interested
- individuals. It is carried in several countries, particularly in the
- Americas and Europe.
-
- Sci.med.aids is moderated by a team. When you submit an article to
- sci.med.aids, it must be approved by a member of the moderation team.
-
- -------------------------------------------------------------------------------
-
- Question 1.2. Discussion topics.
-
- Sci.med.aids covers topics of interest to people with AIDS (Acquired
- Immune Deficiency Syndrome), their friends, relatives, and loved ones,
- AIDS service providers, educators and researchers, and the general public.
-
- Some common topics are
- Causes of AIDS and opportunistic infections.
- Vaccines for AIDS.
- Treatments or cures for AIDS and opportunistic infections.
- AIDS prevention and education.
-
- Sci.med.aids carries some regular magazines. Here's a current list:
- CDC AIDS Daily Summary
- AIDS Treatment News
- The Veterans Administration AIDS Info Newsletter
-
- If you have the time to add to this list, we invite you to contribute (if
- you obtain copyright permission, of course).
-
- -------------------------------------------------------------------------------
-
- Question 1.3. Sci.med.aids distribution.
-
- Sci.med.aids is distributed as a USENET newsgroup, where it has
- approximately 40,000 readers. At one time USENET was carried primarily at
- research and educational institutions, but that is changing; a number of
- commercial services now carry USENET.
-
- Here is a breakdown of comparable newsgroups, for the month of September
- 1993. You can obtain a full list of network traffic by anonymous ftp from
-
- ftp.uu.net:/usenet/news.lists/USENET_Readership_report_for_Sep_93.Z
-
- +-- Estimated total number of people who read the group, worldwide.
- | +-- Actual number of readers in sampled population
- | | +-- Propagation: how many sites receive this group at all
- | | | +-- Recent traffic (messages per month)
- | | | | +-- Recent traffic (kilobytes per month)
- | | | | | +-- Crossposting percentage
- | | | | | | +-- Cost ratio: $US/month/rdr
- | | | | | | | +-- Share: % of newsrders
- | | | | | | | | who read this group.
- V V V V V V V V
-
- 39 110000 1700 76% 3845 6418.0 6% 0.07 3.6% soc.motss
- 77 96000 1420 67% 1885 3541.1 11% 0.04 3.0% alt.drugs
- 131 81000 1203 80% 1571 4064.6 13% 0.06 2.6% sci.med
- 231 65000 961 61% 1269 2863.5 6% 0.04 2.0% alt.politics.homosexuality
- 558 44000 647 66% 282 760.5 38% 0.02 1.4% talk.politics.drugs
- ---------------------------------------------------------
- 605 41000 615 78% 383 1556.0 2% 0.05 1.3% sci.med.aids
- ---------------------------------------------------------
- 724 37000 545 68% 512 1053.6 12% 0.03 1.2% sci.med.nutrition
- 729 37000 542 77% 53 96.0 12% 0.00 1.2% sci.med.physics
- 880 32000 481 43% 436 1033.5 8% 0.02 1.0% alt.homosexual
- 1202 25000 370 41% 326 529.6 9% 0.01 0.8% alt.drugs.caffeine
- 1320 22000 332 21% 27 62.4 4% 0.00 0.7% alt.sex.homosexual
- 1343 22000 326 66% 48 89.1 7% 0.00 0.7% sci.med.occupational
- 1398 21000 314 35% 182 2557.2 0% 0.07 0.7% bit.listserv.gaynet
- 1412 21000 310 56% 145 510.1 0% 0.02 0.7% sci.med.telemedicine
- 1425 21000 307 59% 97 353.2 0% 0.02 0.7% sci.med.dentistry
- 1559 19000 276 48% 99 138.4 8% 0.01 0.6% sci.med.pharmacy
- 1685 17000 254 42% 235 378.1 0% 0.02 0.5% alt.med.cfs
- 1888 14000 213 13% 12 29.3 100% 0.00 0.5% clari.news.law.drugs
- 1916 14000 207 38% 5 19.7 20% 0.00 0.4% bionet.molbio.hiv
- 2449 3500 52 11% 55 97.5 6% 0.01 0.1% de.sci.medizin
-
- Sci.med.aids is also distributed as electronic mail by the AIDS listserv.
- Mail is not as convenient a way to read sci.med.aids as is a newgroup, but
- mail is available at more sites (including Compuserve, America Online,
- MCImail, ATTmail and many institutions which have Internet gateways).
-
- In additional to these primary distributions, sci.med.aids is
- redistributed by various bulletin boards and mail gateways.
-
- -------------------------------------------------------------------------------
-
- Question 1.4. Subscribing and unsubscribe to sci.med.aids.
-
- The answer to this question depends on your system. You may have to ask
- your local system administrator. Here are some guidelines valid on many
- systems:
-
- * You may have USENET on your system, especially if you run UNIX or VMS.
- Here are some commands to try: "rn", "trn", "xrn", "nn", "tin". If
- they work, try joining the newsgroup "sci.med.aids".
-
- That might not work, since some sites limit the newsgroups they receive.
- All is not lost: you can get sci.med.aids by e-mail.
-
- * If USENET is not available you can get sci.med.aids by e-mail. Send a
- mail message to listserv@rutvm1.rutgers.edu. The message body should
- contain just the following command:
- subscribe aids <yourname>
-
- Type in your real name (not your e-mail address) instead of <yourname>.
- A complete message might look like this:
- To: listserv@rutvm1.rutgers.edu
- Subject:
-
- subscribe aids Joe Smith
-
- To unsubscribe, send a message to listserv@rutvm1.rutgers.edu containing
- the text
- unsubscribe aids
-
- Please unsubscribe before your account expires. The moderators get all
- sorts of junk mail if you don't.
-
- -------------------------------------------------------------------------------
-
- Question 1.5. What is a moderated newsgroup?
-
- A moderated newsgroup is one in which all postings must be approved by a
- moderator before being distributed. The purpose of moderation is to
- restrict what can appear. Postings which do not adhere to the guidelines
- for the group will be rejected.
-
- -------------------------------------------------------------------------------
-
- Question 1.6. Editorial guidelines.
-
- As with any newsgroup, read sci.med.aids for a few days before posting, to
- see if your question has been answered already, and to get a feel for the
- tone of the group.
-
- Postings to sci.med.aids should:
-
- * Write on topics directly relevant to AIDS, HIV, or related topics.
-
- * Unconventional medical/research claims must be accompanied by references
- to the popular press (i.e., major newspaper, magazine, etc.) or
- scientific press (i.e., Science, Nature, Lancet, Scientific American,
- Cell, Brain Research, etc.).
-
- We require references for unconventional medical/research claims,
- because some therapies carry with them potential danger. Some
- unconventional medical/research claims are fallacious. Without this
- policy, sci.med.aids would have printed several dangerous and
- undocumented therapies by now.
-
- * Political, sociological opinion/analysis articles are acceptable. The
- interpretation, and even the existence, of this particular policy
- continues to be the subject of internal debate among the moderators.
-
- However, in the past we have printed articles holding both popular and
- unpopular opinions on topics like "Quarantining HIV Positives" or "who
- did Clinton appoint to the AIDS Task Force."
-
- * Refrain from personally attacking other participants. For example, do
- not call someone an 'idiot' or say they are 'biased'. Instead, point
- out the flaws in their argument. If you find yourself getting angry at
- a poster, and construct a reply, please try to remember this rule.
-
- It is often useful to wait a day to see what other reactions have been
- posted before sending something off in anger.
-
- * Send one line "quips" as personal mail to the original submitter, rather
- than posting.
-
- * When posing a question to a previous poster, reconsider whether the
- question needs to be posted. Perhaps you could ask the question by
- e-mail and request a posted response.
-
- * Do not invoke religion.
-
- * Do not break copyright laws. Reprints of articles from other sources
- must include a statement of permission to reprint. An exception is made
- for abstracts of articles from scientific journals, which are not
- usually restricted. If you can't get reprint permission, excerpt or
- summarize the article.
-
- * Do not construct an article with more than 20% text from a previous
- article, unless it is very old (i.e., months old). The best approach
- when constructing a response is to tersely summarize the article to
- which you respond, in square brackets. For example,
-
- In article <11233@sci.med.aids>, Dan Greening wrote:
- > [reasons to not include too much of a prior article]
-
- Also, don't forget that many people get this stuff by mail, so
- huge inclusions clog hundreds of mailboxes, including mine. Thanks.
-
- * Do not duplicate something which has recently appeared.
-
- The moderators don't always agree on what's acceptable and what's not.
-
- If an article is rejected, you should receive a note from the moderator
- saying why. These notes, and other discussions about the running of
- sci.med.aids will be distributed on the aids-d mailing list (see Q1.10
- `Discussing sci.med.aids moderation policies.').
-
- -------------------------------------------------------------------------------
-
- Question 1.7. How do I submit a posting?
-
- This depends on the software you are using. On many USENET systems, you
- can use the command
- postnews
-
- You can also post by sending your article as e-mail to aids@cs.ucla.edu.
-
- Because sci.med.aids is moderated, your submission will not appear
- immediately. Sometimes the delay is very short; often it may be 24 hours.
- It depends on network delays and how busy the moderators are. A tickler
- program reminds us of postings older than 48 hours.
-
- IMPORTANT: Whether you use postnews or e-mail, please format your article
- exactly the way you want it to appear in the newsgroup. Because our
- moderation software is somewhat unpolished, editing out notes to the
- moderators in a posting is quite tedious. If you must communicate
- directly with the moderators, send a note to aids-request@cs.ucla.edu.
-
- -------------------------------------------------------------------------------
-
- Question 1.8. The moderators.
-
- Three people currently moderate sci.med.aids. They are
- Phil Miller Professor, Biostatistics, Washington University
- Jack Hamilton Interested layperson
- Dan Greening Founder sci.med.aids, Director AppWare C++, Novell
- Michelle Murrain Health issues researcher, Professor, Hampshire College
-
- Phil and Jack do most of the moderation. Dan repairs the moderation
- software. Phil is probably the most liberal moderator, Dan the most
- restrictive, Jack in-between. Michelle is new, so it's too early to tell.
-
- Various individuals have been moderators in the past, including
- David Dodell Founder, Grand Rounds fidonet echo, Dentist
- Steve Dyer Writer, Gay Community News, Software Consultant
- Alan Wexelblat Freelance writer, ethicist
- Tom Lincoln Informatics Director, USC Medical Center
- Craig Werner MD/PhD Student, Albert Einstein School of Medicine
- Will Doherty Gay Activist, technical writer Sun Microsystems
-
- -------------------------------------------------------------------------------
-
- Question 1.9. Cooperative moderation.
-
- Cooperative moderation seeks to limit the burn-out associated with
- newsgroup moderation, by sharing the workload among several moderators.
- In addition, it provides a more balanced treatment of contentious issues.
-
- An early paper on the sci.med.aids cooperative moderation scheme is
-
- D.R. Greening and A.D. Wexelblat, Experiences with Cooperative Moderation
- of a USENET Newsgroup, Proceedings of the 1989 ACM/IEEE Workshop on
- Applied Computing.
-
- available by FTP from
- cs.ucla.edu:pub/aids.paper.ps.Z
-
- This paper is also available from the UCLA Computer Science Department as
- a technical report.
-
- -------------------------------------------------------------------------------
-
- Question 1.10. Discussing sci.med.aids moderation policies.
-
- A separate mailing list, aids-d, has been set up for the moderators and
- for people who interested in how sci.med.aids is run. Most readers will
- not be interested in aids-d; its purpose is internal discussion rather
- than information dissemination, and most articles on aids-d are examples
- of what moderation has filtered out. If you want to subscribe, send email
- to aids-d-request@sti.com.
-
- ===============================================================================
-
- Section 2. How to prevent infection.
-
- Q2.1 How is AIDS transmitted?
- Q2.2 How effective are condoms?
- Q2.3 How do you minimize your odds of getting infected?
- Q2.4 How risky is a blood transfusion?
- Q2.5 Can mosquitoes transmit AIDS?
- Q2.6 What about other insect bites?
- Q2.7 Is there even a remote chance of insect transmission?
-
- -------------------------------------------------------------------------------
-
- Question 2.1. How is AIDS transmitted?
-
- The Human Immunodeficiency Virus and Its Transmission
- CDC National AIDS Clearinghouse
-
- Research has revealed a great deal of valuable medical, scientific, and
- public health information about the human immunodeficiency virus (HIV) and
- acquired immmunodeficiency syndrome (AIDS). The ways in which HIV can be
- transmitted have been clearly identified. Unfortunately, some widely
- dispersed information does not reflect the conclusions of scientific
- findings. The Centers for Disease Control and Prevention (CDC) provides
- the following information to help correct a few commonly held
- misperceptions about HIV.
-
- Transmission
-
- HIV is spread by sexual contact with an infected person, by needle-sharing
- among injecting drug users, or, less commonly (and now very rarely in
- countries where blood is screened for HIV antibodies), through
- transfusions of infected blood or blood clotting factors. Babies born to
- HIV-infected women may become infected before or during birth, or through
- breast-feeding after birth.
-
- In the health-care setting, workers have been infected with HIV after
- being stuck with needles containing HIV-infected blood or, less
- frequently, after infected blood gets into the worker's bloodstream
- through an open cut or splashes into a mucous membrane (e.g., eyes or
- inside of the nose). There has been only one demonstrated instance of
- patients being infected by a health-care worker; this involved HIV
- transmission from an infected dentist to five patients. Investigations
- have been completed involving more than 15,000 patients of 32 HIV-infected
- doctors and dentists, and no other cases of this type of transmission have
- been identified.
-
- Some people fear that HIV might be transmitted in other ways; however, no
- scientific evidence to support any of these fears has been found. If HIV
- were being transmitted through other routes (for example, through air or
- insects), the pattern of reported AIDS cases would be much different from
- what has been observed, and cases would be occurring much more frequently
- in persons who report no identified risk for infection. All reported
- cases suggesting new or potentially unknown routes of transmission are
- promptly and thoroughly investigated by state and local health departments
- with the assistance, guidance, and laboratory support from CDC; no
- additional routes of transmission have been recorded, despite a national
- sentinel system designed to detect just such an occurrence.
-
- The following paragraphs specifically address some of the more common
- misperceptions about HIV transmission.
-
- HIV in the Environment
-
- Scientists and medical authorities agree that HIV does not survive well in
- the environment, making the possibility of environmental transmission
- remote. HIV is found in varying concentrations or amounts in blood,
- semen, vaginal fluid, breast milk, saliva, and tears. (See below, Saliva,
- Tears, and Sweat.) In order to obtain data on the survival of HIV,
- laboratory studies have required the use of artificially high
- concentrations of laboratory-grown virus. Although these unnatural
- concentrations of HIV can be kept alive under precisely controlled and
- limited laboratory conditions, CDC studies have showned that drying of
- even these high concentrations of HIV reduces the number of infectious
- viruses by 90 to 99 percent within several hours. Since the HIV
- concentrations used in laboratory studies are much higher than those
- actually found in blood or other specimens, drying of HIV- infected human
- blood or other body fluids reduces the theoretical risk of environmental
- transmission to that which has been observed- -essentially zero.
- Incorrect interpretation of conclusions drawn from laboratory studies have
- alarmed people unnecessarily. Results from laboratory studies should not
- be used to determine specific personal risk of infection because 1) the
- amount of virus studied is not found in human specimens or anyplace else
- in nature, and 2) no one has been identified with HIV due to contact with
- an environmental surface; Additionally, since HIV is unable to reproduce
- outside its living host (unlike many bacteria or fungi, which may do so
- under suitable conditions), except under laboratory conditions, it does
- not spread or maintain infectiousness outside its host.
-
- Households, Offices, and Workplaces
-
- Studies of thousands of households where families have lived with and
- cared for AIDS patients have found no instances of nonsexual transmission,
- despite the sharing of kitchen, laundry, and bathroom facilities, meals,
- eating utensils, and drinking cups and glasses. If HIV is not transmitted
- in these settings, where repeated and prolonged contact occurs,
- transmission is even less likely in other settings, such as schools and
- offices.
-
- Similarly, there is no known risk of HIV transmission to co- workers,
- clients, or consumers from contact in industries such as food service
- establishments (see information on survival of HIV in the environment).
- Food service workers known to be infected with HIV need not be restricted
- from work unless they have other infections or illinesses (such as
- diarrhea or hepatitis A) for which any food service worker, regardless of
- HIV infection status, should be restricted; The Public Health Service
- recommends that all food service workers follow recommended standards and
- practices of good personal hygiene and food sanitation.
-
- Kissing
-
- Casual contact through closed-mouth or "social" kissing is not a risk for
- transmission of HIV. Because of the theoretical potential for contact
- with blood during "French" or open-mouthed kissing, CDC recommends against
- engaging in this activity with an infected person. However, no case of
- AIDS reported to CDC can be attributed to transmission through any kind of
- kissing.
-
- Saliva, Tears, and Sweat
-
- HIV has been found in saliva and tears in only minute quantities from some
- AIDS patients. It is important to understand that finding a small amount
- of HIV in a body fluid does not necessarily mean that HIV can be
- transmitted by that body fluid. HIV has not been recovered from the sweat
- of HIV-infected persons. Contact with saliva, tears, or sweat has never
- been shown to result in transmission of HIV.
-
- Insects
-
- From the onset of the HIV epidemic, there has been concern about
- transmission of the virus by biting and blood-sucking insects. However,
- studies conducted by researchers at CDC and elsewhere have shown no
- evidence of HIV transmission through insects--even in areas where there
- are many cases of AIDS and large populations of insects such as
- mosquitoes. Lack of such outbreaks, despite intense efforts to detect
- them, supports the conclusion that HIV is not transmitted by insects.
-
- The results of experiments and observations of insect biting behavior
- indiciate that when an insect bites a person, it does not inject its own
- or a previous victim's blood into the new victim. Rather, it injects
- saliva. Such diseases as yellow fever and malaria are transmitted through
- the saliva of specific species of mosquitoes. However, HIV lives for only
- a short time inside an insect and, unlike organisms that are transmitted
- via insect bites, HIV does not reproduce (and, therefore, cannot survive)
- in insects. Thus, even if the virus enters a mosquito or another sucking
- or biting insect, the insect does not become infected and cannot transmit
- HIV to the next human it feeds on or bites.
-
- There is also no reason to fear that a biting or blood-sucking insect,
- such as a mosquito, could transmit HIV from one person to another through
- HIV-infected blood left on its mouth parts. Two factors combine to make
- infection by this route extremely unlikely-- first, infected people do not
- have constant, high levels of HIV in their bloodstreams and, second,
- insect mouth parts do not retain large amounts of blood on their surfaces.
- Further, scientists who study insects have determined that biting insects
- normally do not travel from one person to the next immediately after
- ingesting blood.
-
- Effectiveness of Condoms
-
- The proper and consistent use of latex condoms when engaging in sexual
- intercourse--vaginal, anal, or oral--can greatly reduce a person's risk of
- acquiring or transmitting sexually transmitted diseases, including HIV
- infection.
-
- Under laboratory conditions, viruses occasionally have been shown to pass
- through natural membrane ("skin" or lambskin) condoms, which contain
- natural pores and are therefore not recommended for disease prevention.
- On the other hand, laboratory studies have consistently demonstrated that
- latex condoms provide a highly effective mechanical barrier to HIV.
-
- In order for condoms to provide maximum protection, they must be used
- consistently (every time) and correctly. Incorrect use contributes to the
- possibility that the condom could leak or break. Proper use should
- include the following:
-
- * Put on the condom as soon as erection occurs and before any sexual
- contact (vaginal, anal, or oral).
-
- * Leave space at the tip of the condom.
-
- * Use only water-based lubricants. (Oil-based lubricants can weaken the
- condom.)
-
- * Hold the condom firmly to keep it from slipping off and withdraw from
- the partner immediately after ejaculation.
-
- When condoms are used reliably, they have been shown to prevent pregnancy
- up to 98 percent of the time among couples using them as their only method
- of contraception. Similarly, numerous studies among sexually active
- people have demonstrated that a properly used latex condom provides a high
- degree of protection against a variety of sexually transmitted diseases,
- including HIV infection.
-
- Condoms are classified as medical devices and are regulated by the Food
- and Drug Administration. Each latex condom manufactured in the United
- States is tested for defects, including holes, before it is packaged, and
- several studies clearly show that condom breakage rates in this country
- are less than 2 percent. Even when condoms do break, one study showed
- that more than half of such breaks occurred prior to ejaculation.
-
- Latex condoms can provide up to 98-99 percent protection against pregnancy
- and most sexually transmitted diseases, including HIV infection, but only
- if they are used consistently and correctly.
-
- For more detailed information about condoms, see CDC's fact sheet, "The
- Role of Condoms in Preventing HIV Infection and Other Sexually Transmitted
- Diseases."
-
- The Public Health Service Response
-
- The U.S. Public Health Service is committed to providing the scientific
- community and the public with accurate and objective information about HIV
- infection and AIDS. It is vital that clear information on HIV infection
- and AIDS be readily available to help prevent further transmission of the
- virus and to allay fears and prejudices caused by misinformation. In
- addition to research on the virus and its transmission, the PHS program to
- prevent the spread of HIV/AIDS includes counseling, testing, and
- education. Through these programs, individuals who have engaged in
- high-risk behaviors can receive voluntary HIV-antibody testing for
- themselves and their partners, and those found to be infected can be
- counseled regarding preventive services and treatment options, as well as
- how to prevent transmission to others.
-
- For more information:
-
- CDC National AIDS Hotline: 1-800-342-AIDS
- Spanish: 1-800-344-7432
- Deaf: 1-800-243-7889
-
- CDC National AIDS Clearinghouse
- P.O. Box 6003
- Rockville, MD 20849-6003
-
- -------------------------------------------------------------------------------
-
- Question 2.2. How effective are condoms?
-
- Update: Barrier Protection against Sexual Diseases
- CDC National AIDS Clearinghouse
-
- Although refraining from intercourse with infected partners remains the
- most effective strategy for preventing human immunodeficiency virus (HIV)
- infection and other sexually transmitted diseases (STDs), the Public
- Health Service also has recommended condom use as part of its strategy.
- Since CDC summarized the effectiveness of condom use in preventing HIV
- infection and other STDs in 1988 (1), additional information has become
- available, and the Food and Drug Administration has approved a
- polyurethane "female condom." This report updates laboratory and
- epidemiologic information regarding the effectiveness of condoms in
- preventing HIV infection and other STDs and the role of spermicides used
- adjunctively with condoms. *
-
- Two reviews summarizing the use of latex condoms among serodiscordant
- heterosexual couples (i.e., in which one partner is HIV positive and the
- other HIV negative) indicated that using latex condoms substantially
- reduces the risk for HIV transmission (2,3). In addition, two subsequent
- studies of serodiscordant couples confirmed this finding and emphasized
- the importance of consistent (i.e., use of a condom with each act of
- intercourse) and correct condom use (4,5). In one study of serodiscordant
- couples, none of 123 partners who used condoms consistently seroconverted;
- in comparison, 12 (10%) of 122 seronegative partners who used condoms
- inconsistently became infected (4). In another study of serodiscordant
- couples (with seronegative female partners of HIV-infected men), three
- (2%) of 171 consistent condom users seroconverted, compared with eight
- (15%) of 55 inconsistent condom users. When person-years at risk were
- considered, the rate for HIV transmission among couples reporting
- consistent condom use was 1.1 per 100 person-years of observation,
- compared with 9.7 among inconsistent users (5). Condom use reduces the
- risk for gonorrhea, herpes simplex virus (HSV) infection, genital ulcers,
- and pelvic inflammatory disease (2). In addition, intact latex condoms
- provide a continuous mechanical barrier to HIV, HSV, hepatitis B virus
- (HBV), Chlamydia trachomatis, and Neisseria gonorrhoeae (2). A recent
- laboratory study (6) indicated that latex condoms are an effective
- mechanical barrier to fluid containing HIV-sized particles. Three
- prospective studies in developed countries indicated that condoms are
- unlikely to break or slip during proper use. Reported breakage rates in
- the studies were 2% or less for vaginal or anal intercourse (2). One
- study reported complete slippage off the penis during intercourse for one
- (0.4%) of 237 condoms and complete slippage off the penis during
- withdrawal for one (0.4%) of 237 condoms (7). Laboratory studies indicate
- that the female condom (Reality (trademark) **) -- a lubricated
- polyurethane sheath with a ring on each end that is inserted into the
- vagina -- is an effective mechanical barrier to viruses, including HIV. No
- clinical studies have been completed to define protection from HIV
- infection or other STDs. However, an evaluation of the female condom's
- effectiveness in pregnancy prevention was conducted during a 6-month
- period for 147 women in the United States. The estimated 12-month failure
- rate for pregnancy prevention among the 147 women was 26%. Of the 86 women
- who used this condom consistently and correctly, the estimated 12-month
- failure rate was 11%. Laboratory studies indicate that nonoxynol-9, a
- nonionic surfactant used as a spermicide, inactivates HIV and other
- sexually transmitted pathogens. In a cohort study among women, vaginal use
- of nonoxynol-9 without condoms reduced risk for gonorrhea by 89%; in
- another cohort study among women, vaginal use of nonoxynol-9 without
- condoms reduced risk for gonorrhea by 24% and chlamydial infection by 22%
- (2). No reports indicate that nonoxynol-9 used alone without condoms is
- effective for preventing sexual transmission of HIV. Furthermore, one
- randomized controlled trial among prostitutes in Kenya found no protection
- against HIV infection with use of a vaginal sponge containing a high dose
- of nonoxynol-9 (2). No studies have shown that nonoxynol-9 used with a
- condom increases the protection provided by condom use alone against HIV
- infection.
-
- Reported by: Food and Drug Administration. Center for Population Research,
- National Institute of Child Health and Human Development, National
- Institutes of Health. Office of the Associate Director for HIV/AIDS; Div
- of Reproductive Health, National Center for Chronic Disease Prevention and
- Health Promotion; Div of Sexually Transmitted Diseases and HIV Prevention,
- National Center for Prevention Svcs; Div of HIV/AIDS, National Center for
- Infectious Diseases, CDC.
-
- Editorial Note: This report indicates that latex condoms are highly
- effective for preventing HIV infection and other STDs when used
- consistently and correctly. Condom availability is essential in assuring
- consistent use. Men and women relying on condoms for prevention of HIV
- infection or other STDs should carry condoms or have them readily
- available.
-
- Correct use of a latex condom requires 1) using a new condom with each act
- of intercourse; 2) carefully handling the condom to avoid damaging it with
- fingernails, teeth, or other sharp objects; 3) putting on the condom after
- the penis is erect and before any genital contact with the partner; 4)
- ensuring no air is trapped in the tip of the condom; 5) ensuring adequate
- lubrication during intercourse, possibly requiring use of exogenous
- lubricants; 6) using only water-based lubricants (e.g., K-Y jelly
- (trademark) or glycerine) with latex condoms (oil-based lubricants (e.g.,
- petroleum jelly, shortening, mineral oil, massage oils, body lotions, or
- cooking oil) that can weaken latex should never be used); and 7) holding
- the condom firmly against the base of the penis during withdrawal and
- withdrawing while the penis is still erect to prevent slippage.
-
- Condoms should be stored in a cool, dry place out of direct sunlight and
- should not be used after the expiration date. Condoms in damaged packages
- or condoms that show obvious signs of deterioration (e.g., brittleness,
- stickiness, or discoloration) should not be used regardless of their
- expiration date.
-
- Natural-membrane condoms may not offer the same level of protection
- against sexually transmitted viruses as latex condoms. Unlike latex,
- natural- membrane condoms have naturally occurring pores that are small
- enough to prevent passage of sperm but large enough to allow passage of
- viruses in laboratory studies (2).
-
- The effectiveness of spermicides in preventing HIV transmission is
- unknown. Spermicides used in the vagina may offer some protection against
- cervical gonorrhea and chlamydia. No data exist to indicate that condoms
- lubricated with spermicides are more effective than other lubricated
- condoms in protecting against the transmission of HIV infection and other
- STDs. Therefore, latex condoms with or without spermicides are
- recommended.
-
- The most effective way to prevent sexual transmission of HIV infection and
- other STDs is to avoid sexual intercourse with an infected partner. If a
- person chooses to have sexual intercourse with a partner whose infection
- status is unknown or who is infected with HIV or other STDs, men should
- use a new latex condom with each act of intercourse. When a male condom
- cannot be used, couples should consider using a female condom.
-
- Data from the 1988 National Survey of Family Growth underscore the
- importance of consistent and correct use of contraceptive methods in
- pregnancy prevention (8). For example, the typical failure rate during the
- first year of use was 8% for oral contraceptives, 15% for male condoms,
- and 26% for periodic abstinence. In comparison, persons who always abstain
- will have a zero failure rate, women who always use oral contraceptives
- will have a near-zero (0.1%) failure rate, and consistent male condom
- users will have a 2% failure rate (9). For prevention of HIV infection and
- STDs, as with pregnancy prevention, consistent and correct use is crucial.
-
- The determinants of proper condom use are complex and incompletely
- understood. Better understanding of both individual and societal factors
- will contribute to prevention efforts that support persons in reducing
- their risks for infection. Prevention messages must highlight the
- importance of consistent and correct condom use (10).
-
- References
-
- 1. CDC. Condoms for prevention of sexually transmitted diseases. MMWR
- 1988;37:133-7.
-
- 2. Cates W, Stone KM. Family planning, sexually transmitted diseases, and
- contraceptive choice: a literature update. Fam Plann Perspect
- 1992;24:75-84.
-
- 3. Weller SC. A meta-analysis of condom effectiveness in reducing sexually
- transmitted HIV. Soc Sci Med 1993;1635-44.
-
- 4. DeVincenzi I, European Study Group on Heterosexual Transmission of HIV.
- Heterosexual transmission of HIV in a European cohort of couples (Abstract
- no. WS-CO2-1). Vol 1. IXth International Conference on AIDS/IVth STD
- World Congress. Berlin, June 9, 1993:83.
-
- 5. Saracco A, Musicco M, Nicolosi A, et al. Man-to-woman sexual
- transmission of HIV: longitudinal study of 343 steady partners of infected
- men. J Acquir Immune Defic Syndr 1993;6:497-502.
-
- 6. Carey RF, Herman WA, Retta SM, Rinaldi JE, Herman BA, Athey TW.
- Effectiveness of latex condoms as a barrier to human immunodeficiency
- virus- sized particles under conditions of simulated use. Sex Transm Dis
- 1992;19:230- 4.
-
- 7. Trussell JE, Warner DL, Hatcher R. Condom performance during vaginal
- intercourse: comparison of Trojan-Enz (trademark) and Tactylon (trademark)
- condoms. Contraception 1992;45:11-9.
-
- 8. Jones EF, Forrest JD. Contraceptive failure rates based on the 1988
- NSFG. Fam Plann Perspect 1992;24:12-9.
-
- 9. Trussell J, Hatcher RA, Cates W, Stewart FH, Kost K. Contraceptive
- failure in the United States: an update. Stud Fam Plann 1990;21:51-4.
-
- 10. Roper WL, Peterson HB, Curran JW. Commentary: condoms and HIV/STD
- prevention -- clarifying the message. Am J Public Health 1993;83:501-3.
-
- * Single copies of this report will be available free until August 6,
- 1994, from the CDC National AIDS Clearinghouse, P.O. Box 6003, Rockville,
- MD 20849- 6003; telephone (800) 458-5231.
-
- ** Use of trade names is for identification only and does not imply
- endorsement by the Public Health Service or the U.S. Department of Health
- and Human Services.
-
- -------------------------------------------------------------------------------
-
- Question 2.3. How do you minimize your odds of getting infected?
-
- "Playing the AIDS Odds" (21 Oct 93)
-
- Robert S. Walker, Ph.D. Phone: (210)224-9172
- Emeritus professor Internet: rwalker@trinity.edu
- Trinity University, Pol.Sci.
- 715 Stadium Drive office: 128 Main Plaza, No.310
- San Antonio, TX 78212 San Antonio, TX, 78205
-
-
- Everyone worries about the degree of transmission-risk involved in various
- activities. Can you get infected from mutual masturbation? From fisting?
- From using poppers? From this and from that? The real question is, "Is it
- possible to provide answers with sufficient precision to allow an
- individual confidently to assess risk and modify behavior in specific
- situations?" The answer is "No." No one knows enough about either sexual
- or drug behaviors, and their relation to HIV sero- conversion, to speak
- with assurance. But this doesn't mean that meaningful recommendations are
- out of the question.
-
- Those interested in risk assessment might read two articles representing
- different approaches. First: Michael Shernoff, "Integrat- ing Safer Sex
- Counseling into Social Work Practice, Social Casework: The Journal of
- Contemporary Social Work, vol. 69 (1988), pp. 334-339. The author offers
- a scaled list of 30 sexual behaviors from abstinence through fisting to
- condomless, receptive anal intercourse. The list is graded from "least
- likely" to transmit virus to "most likely." Some of the relative rankings
- are arguable, but the biggest problem is that the intervals of the "risk"
- scale are not equal. For example, #29 is "vaginal intercourse to orgasm
- without condoms," #30 is "anal inter- course to orgasm without condoms;"
- these two are separated by the same scaler distance as abstinence (no.1)
- and solitary masturbation (no.2). But everyone agrees that, anal
- intercourse is many times more dangerous than vaginal for the receptive
- partner, not just "one interval" more dangerous. Such lists are not too
- useful; I doubt that any subscriber to this list needs to be told that
- solitary masturbation is safer than receptive anal intercourse. Further,
- until a lot more is known about the relationships between specific
- behaviors and sero-conversion, the intervals cannot be meaningfully
- quantified.
-
- The second article is Norman Hearst and Stephen B. Hulley, "Heterosexual
- AIDS," Journal of the American Medical Association, April 22, 1988. The
- authors calculate probabilities for HIV transmission for different
- parameters (such as: the area's seroprevalence rate, the infectiousness of
- a partner, the condom/spermicide failure rate, and the number of sexual
- encounters). The "odds" of transmission with different parameters (such
- as: 500 encounters, .01 condoms failure rate, area seroprevalence of
- .0001, and so forth) are then projected. The resulting odds range from a
- "low" of 1 chance in 5 billion to a "high" of 1 transmission in 500
- encounters. In the lowest risk example, there is 1 in 5 billion chance
- that HIV will be transmitted when: (1) your partner tests negative; (2)
- he/she has no history of high-risk behavior; (3) condoms are used in
- intercourse, and the condom failure rate is .01; (4) the area
- seroprevalence rate is 0.000001, (5) the infectivity value is 0.002; and
- (6) there is only one sexual encounter.
-
- As behavioral guides, neither approach is very helpful. When the possible
- sex or drug scenarios become as disparate as they are in real-life
- situations, and when the odds resemble your chances of winning a major
- lottery, then stating intervals or odds does not provide much more than a
- illusion of knowledge and resulting security.
-
- I suggest a different approach to thinking about risk. First, do not
- worry about practices for which there is no documentation of transmission
- (as distinct from speculation about it). If there is any risk in kissing,
- masturbation, skinny-dipping or whatever, it is probably much less than
- the chance of being hit by lightning - and few people worry about that.
- Focus on those activities, like intercourse and/or injecting drugs, which
- common sense tells you are risky, if for no other reason than that they
- have a long history of transmitting other diseases (like syphilis or
- hepatitis). Such behaviors would clearly include injecting drug use
- within a group, condomless anal and/or vaginal intercourse, and less
- clearly oral sex, fisting, or any S&M practice that involved a possible
- blood exchange.
-
- Second, take into account the overall setting within sexual or drug
- activity is taking place. While it seems that we are all biologically at
- equal risk, we do not face equal environmental risks. While HIV
- theoretically can spread uniformly from the North to the South pole, it
- has not in fact done so. It is one thing to pick up someone at a bar in
- Brahma, Oklahoma and another in San Francisco, California. The risk
- involved in employing a prostitute in Des Moines is much less than in
- Newark, NJ or Washington D.C. where the seroprevalence rate among
- prostitutes is very high. Similarly, patronizing a Newark shooting gallery
- or crack house is like asking for AIDS, but the risk of transmission
- within the West Coast drug scene is much less. For area comparisons see
- the Centers for Disease Control's quarterly HIV/AIDS Surveillance Report,
- and/or Jonathan Mann et al, AIDS in the World, Harvard U. Press, 1993.
-
- What I am suggesting is that some information plus common sense is a
- better guide than current statistical or quasi-statistical statements
- about relative risk. This will remain the case until a great deal more
- empiric data is amassed about some of our most private behaviors. If you
- are a person who does not feel comfortable without precise, reliable,
- quantified guidelines, then your only course is to abstain from activities
- wherein there is a possibility of transmission. There are many
- mood-altering substances that do not require injection, and a lot of
- sexual behavior that does not involve penetration and fluid exchange.
-
- With respect to non-sex or drug modes of transmission, all one can say is
- that there have been no documented cases of transmission through insect
- bites, shared utensils, shared occupational space or equipment, food
- handling, and so on. Theoretical risks for an infinite number of imagined
- scenarios can be computed, but in the actual world there are no data
- supporting transmission in these scenarios. An excellent survey of 14
- principal articles searching for data on other routes of transmission can
- be found in: Robyn R.N Gershon et al, "The Risk of Transmission of HIV-1
- Through Non-Percutaneous, Non-Sexual Modes: A Review," Department of
- Environmental Health Sciences and Department of Epidemiology, The Johns
- Hopkins University School of Hygiene and Public Health, distribut- ed by
- New York City's Gay Men's Health Crisis, AIDS Clinical Update, October 1,
- 1990. There have been cases of transmission through transfusions
- /transplants of contaminated whole blood, blood products, donor organs,
- and dental work. The only thing one can do is to be aware of the
- possibility, and make sure that those who treat you take all precautions.
-
- Currently, the only way to load the dice in your favor is to use common
- sense in any situation wherein someone else's body fluids might be
- introduced into yours through sexual or drug behaviors. If one can
- foresee that there would be opportunity for fluid exchange - blood, semen,
- vaginal secretions - then a large measure of safety can be had from the
- use of condoms (see: Condom Faq) and/or your own works for injecting
- drugs. The only safer course - and it is an honorable and intelligent one
- - would be to abstain from such activities altogether.
-
- What must be kept in mind is that the risk of HIV transmission is totally
- unlike the risk of losing at the races. Because you cannot recoup the
- loss represented by infection, you ought not think of the "odds" in the
- same way. In fact, it is better not to focus on the so- called "odds" at
- all. Given that (1) infection almost always leads to AIDS (estimates=95%),
- and (2) that AIDS almost always leads to death (estimates=99%), people
- must now think of sex or injecting drug use as an all-or-nothing game, .
- Each time you play, there are only two possible outcomes. If you win you
- have, perhaps, enjoyed a pleasant encounter; if you lose, you die. And
- each time you play without regard to common sense evaluation and personal
- protection, you enhance the possibility that you will lose. Its as simple
- as that.
-
- -------------------------------------------------------------------------------
-
- Question 2.4. How risky is a blood transfusion?
-
- The following October 15, 1993 United Press International article, was
- summarized in the CDC AIDS Daily News Summary.
-
- "CDC Study Finds Five Transfusion-Related AIDS Cases Per Year" United
- Press International (10/25/93)
-
- Miami Beach, Fla.--Since screening for HIV began in 1985, very few people
- have become infected with the virus via blood transfusions, according to
- experts at the Centers for Disease Control and Prevention. The rate of
- transfusion-related AIDS cases rose steadily from 1978 to 1984, then fell
- dramatically when testing began in 1985, said the CDC. Officials report
- that between 1986 and 1991, the number of such cases may have been as low
- as five per year. "While the risk of getting AIDS from a transfusion is
- not zero, this study corroborates other CDC research and published data
- indicating that the risk is extremely low," said Dr. Arthur J.
- Silvergleid, president of the American Association of Blood Banks. A
- total of 4,619 individuals are believed to have been infected through the
- blood supply. Each year in the United States, about 4 million people
- receive blood transfusions.
-
- -------------------------------------------------------------------------------
-
- Question 2.5. Can mosquitoes transmit AIDS?
-
- Please see Q2.1 `How is AIDS transmitted?' for general information about
- insects and AIDS transmission.
-
- Malaria is transmitted to humans through mosquito bites. Why can't AIDS
- be transmitted this way?
-
- Plasmodium, the protozoan that causes malaria, is highly specialized to
- infect through a mosquito vector. The gametocytes ingested by the mosquito
- from an infected host undergo a further stage of development and give rise
- to sporozoites. These migrate through the insects body until they reach
- the salivary glands . They are then injected into a new host by the
- mosquito along with its saliva which is an anti-coagulant and needed to
- stop clotting.
-
- -------------------------------------------------------------------------------
-
- Question 2.6. What about other insect bites?
-
- From: "Natural History", July 1991, p. 54:
-
- Acquired Immune Deficiency Syndrome (AIDS), the deadly epidemic caused by
- the HIV virus, is most often transmitted by contaminated hypodermic
- needles or sexual contact. Since mosquitos feed on human blood and may
- attack a series of individuals, the question arises: can you get AIDS from
- a mosquito bite?
-
- According to Jonathan F. Day, of the University of Florida's Medical
- Entomology Laboratory, insects can transmit viruses in two ways,
- mechanically and biologically. With mechanical transmission, infected
- blood on the insect's mouthparts might be carried to another host while
- the blood is still fresh and the virus still alive. Infection by this
- means is possible but highly unlikely, because mosquitos seldom have fresh
- blood on the outside of their mouthparts. Mechanical transmission does
- occur in horses, however, with equine infectious anemia, a virus closely
- related to AIDS and transmitted by horseflies. These flies are "pool
- feeders"; their bite causes a small puddle of blood to form, and they
- immerse their mouthparts, head, and front legs while lapping it up. If
- disturbed, however, they quickly move on to another horse, where the fresh
- blood of the two hosts may mingle. Blood-feeding mosquitos are much neater
- and more surgical; they insert a tube for drawing blood, and by the time
- they are ready for their next meal, even on a second host following an
- interrupted meal, any viruses from their first meal are safely stored away
- in their midgut.
-
- With biological transmission, the pathogen must complete a portion of its
- life cycle within the carrier, or vector species. Protozoans that cause
- malaria, for instance, go through an extremely complex cycle within the
- mosquito, eventually congregating in the salivary glands, from which they
- may infect avian, primate, rodent, or reptilian hosts, depending on the
- malaria species. The HIV virus, however, does not replicate or develop in
- the mosquito; once in the insect's gut, the virus quickly dies. Repeated
- studies since 1986 show that AIDS-infected blood fed to mosquitos and
- other arthopods does not live to be passed on and that, fortunately, there
- is no biological-transmission cycle of AIDS in blood-feeding arthopods,
- which frequently ingest the virus as part of their blood meal.
-
- -------------------------------------------------------------------------------
-
- Question 2.7. Is there even a remote chance of insect transmission?
-
- An interesting paper is:
-
- Do Insects Transmit Aids?
- by Lawrence Miike
-
- Health Program; Office of Technology Assessment
- United States Congress; Washington D.C. 20510-8025
- September 1987 -- A Staff Paper in OTA's Series on
- AIDS-Related Issues
-
- For sale by the Superintendent of Documents
- U.S. Government Printing Office
- Washington, D.C. 20402
-
- This paper indicates that "The conditions necessary for successful
- transmission of HIV through insect bites, and the probabilities of their
- occurring, rule out the possiblility of insect transmission of HIV
- infection as a significant factor in the way AIDS is spread. If insect
- transmission is occurring at all, each case would be a rare and unusual
- event."
-
- Miike suggests that there are two theoretical mechanisms by which biting
- insects might transmit HIV infections: 1). biological (insect's saliva
- to person's blood) and 2). mechanical (HIV-infected person's fresh blood
- to another's blood). Based on experimental results, they were able to
- rule out biological transmission. This leaves mechanical transmission
- during interrupted feeding as a viable mechanism. So it COULD happen;
- HOWEVER...
-
- "The probability of HIV transmission from an insect bite would be
- calculated by multiplying (not adding, because each event's probability is
- independent of each other) the following factors: 1) how frequently
- interrupted feeding occurs, 2) the probability the the insect had bitten
- an HIV-infected person prior to biting an uninfected person, and 3) the
- probability that the insect bite contained enough HIV to transmit
- infection."
-
- "The frequency of interrupted feeding depends on the type of insect; in
- general, the larger the insect and the more painful the bite -- such as
- horse flies -- the greater the probability that interrupted feeding will
- occur. Other bites, such as from mosquitoes and bedbugs, are usually
- unnoticed and therefore usually uninterrupted. With others, such as
- ticks, if their feeding is interrupted, the probability of quickly
- transferring to another person is extremely low."
-
- "In mechanical transmission, the maximum amount of HIV that insects would
- be able to transfer would be the amount of virus in the blood they had
- ingested prior to biting an uninfected person. Experience with viruses
- actually transferred in this manner has shown that the amount of blood
- that might be transferred is limited to the amount of blood on the
- insect's mouthparts (on the order of 1/100,000 of a milliliter of blood).
- An uninfected person would also have to be bitten within an hour of the
- insect's biting an infected person; and both infected and uninfected
- persons would have to be in close proximity to each other (a few hundred
- feet for mosquitoes and biting flies, in the same household for bedbugs),
- or else the insect will not have an opportunity to transfer to another
- person if its feeding was interrupted."
-
- "Most HIV-infected persons (70-80 percent) do not have detectable levels
- of infectious virus in their blood. Those that do have measurable HIV
- have very low levels, much below the levels that are needed for insect
- transmission of other viral diseases. Only rarely does an HIV-infected
- person have a blood virus level that might contain enough infectious HIV
- for insect transmission."
-
- There you go... it seems that you CAN become HIV-infected via a mosquito
- bite. Then again, you CAN also win the multi-million dollar lotto game
- five times consecutively! 8-) I wouldn't lose any sleep worrying about
- either of those.
-
-